How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond
J Rimando, SR McCurdy, L Luznik - Blood, 2023 - ashpublications.org
Advances in conditioning, graft-versus-host disease (GVHD) prophylaxis and antimicrobial
prophylaxis have improved the safety of allogeneic hematopoietic cell transplantation (HCT) …
prophylaxis have improved the safety of allogeneic hematopoietic cell transplantation (HCT) …
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
National Marrow Donor Program–sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant …
PURPOSE Hematopoietic cell transplantation (HCT) is curative for hematologic disorders,
but outcomes are historically inferior when using HLA-mismatched donors. Despite …
but outcomes are historically inferior when using HLA-mismatched donors. Despite …
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
M Gooptu, R Romee, A St. Martin… - Blood, The Journal …, 2021 - ashpublications.org
Posttransplant cyclophosphamide (PTCy) graft-versus-host disease (GVHD) prophylaxis has
enabled haploidentical (Haplo) transplantation to be performed with results similar to those …
enabled haploidentical (Haplo) transplantation to be performed with results similar to those …
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute …
A Ruggeri, M Labopin, A Bacigalupo… - Journal of hematology & …, 2018 - Springer
Background Experience using post-transplant cyclophosphamide (PT-Cy) as graft-versus-
host disease (GVHD) prophylaxis in allogeneic stem cell transplantation (HSCT) from …
host disease (GVHD) prophylaxis in allogeneic stem cell transplantation (HSCT) from …
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide
BACKGROUND Incidence of graft‐versus‐host disease (GVHD) in haploidentical bone
marrow (BM) transplants using posttransplantion cyclophosphamide (PT‐Cy) is low …
marrow (BM) transplants using posttransplantion cyclophosphamide (PT‐Cy) is low …
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation
Post-transplant cyclophosphamide (PT-Cy) is effective for graft-versus-host disease (GVHD)
prophylaxis, but it may cause dose-dependent toxicities, particularly in frail patients …
prophylaxis, but it may cause dose-dependent toxicities, particularly in frail patients …
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
A Rashidi, M Hamadani, MJ Zhang, HL Wang… - Blood …, 2019 - ashpublications.org
HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) using
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study …
J Sanz, JE Galimard, M Labopin, B Afanasyev… - Journal of hematology & …, 2020 - Springer
Background The use of post-transplant cyclophosphamide (PTCy) is highly effective in
preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting …
preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting …
Combining post-transplant cyclophosphamide with antithymocyte globulin for graft-versus-host disease prophylaxis in hematological malignancies
In search of an ideal partner or alternative to conventional immunosuppressive agents,
rabbit anti-thymocyte globulin (ATG) and, more recently, post-transplant cyclophosphamide …
rabbit anti-thymocyte globulin (ATG) and, more recently, post-transplant cyclophosphamide …